- AU$2.61m
- AU$3.93m
- AU$7.62m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.72 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.34 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -33.41% | ||
| Return on Equity | 2.98% | ||
| Operating Margin | -9.98% | ||
Financial Summary
| Year End 30th Jun | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.74 | 4.43 | 4.98 | 7.23 | 7.62 | n/a | n/a | 120.18% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Careteq Limited is an Australia-based health-tech company. The Company is focused on medication management solutions. The Company’s brands include Embedded Health Solutions (EHS) and HMR Referrals platforms. The EHS provides comprehensive aged care medication management solutions through Residential Medication Management Reviews (RMMRs), while HMR Referrals streamlines Home Medicines Reviews (HMRs). The Services provided on the HMR Referrals marketplace platform that simplifies and streamlines the HMR processes for general practitioners (GPs) and accredited pharmacists. The HRMs are conducted by a pharmacist with the patient at their home to provide helpful advice on their medications and to optimize their effectiveness.
Directors
- Mark Simari NEC (50)
- Peter Scala CEO
- David Lilja CFO
- Alexander Boyd COO
- Brett Cheong NID (59)
- Stephen Munday NID (54)
- Last Annual
- June 30th, 2025
- Last Interim
- June 30th, 2025
- Incorporated
- May 7th, 2016
- Public Since
- January 10th, 2022
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 237,118,720
- Address
- Level 10, 99 Queen St, MELBOURNE, 3000
- Web
- https://www.careteq.com.au/
- Phone
- +61 388665594
- Auditors
- RSM Australia Partners
Upcoming Events for CTQ
Similar to CTQ
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
CLEO Diagnostics
Australian Stock Exchange - SEATS
FAQ
What is the Careteq share price?
As of Today at 19:48 UTC, shares in Careteq are trading at AU$0.01. This share price information is delayed by 15 minutes.
How has the Careteq share price performed this year?
Shares in Careteq last closed at AU$0.01 and the price had moved by -15.38% over the past 365 days. In terms of relative price strength the Careteq share price has underperformed the ASX All Ordinaries Index by -21.48% over the past year.
What are the analyst and broker recommendations for Careteq?
There is no consensus recommendation for this security.
Find out moreWhat is the Careteq dividend yield?
Careteq does not currently pay a dividend.
Does Careteq pay a dividend?
Careteq does not currently pay a dividend.
When does Careteq next pay dividends?
Careteq does not currently pay a dividend.
How do I buy Careteq shares?
To buy shares in Careteq you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Careteq?
As of the previous close price of AU$0.01, shares in Careteq had a market capitalisation of AU$2.61m.
Where are Careteq shares listed?
Here are the trading details for Careteq:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CTQ
What kind of share is Careteq?
Based on an overall assessment of its quality, value and momentum Careteq is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Careteq share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Careteq share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Careteq. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -13.77%.
As of the last closing price of AU$0.01, shares in Careteq were trading -13.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Careteq PE Ratio?
The Careteq PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Careteq?
Careteq's management team is headed by:
- Mark Simari - NEC
- Peter Scala - CEO
- David Lilja - CFO
- Alexander Boyd - COO
- Brett Cheong - NID
- Stephen Munday - NID